Reach Separations Competitors and Similar CompaniesClear all

Reach Separations's competitors and similar companies include Boiron, Asembia, China Medical System and Navitus Health Solutions.

	Reach Separations Reach Separations specializes in chromatography for the analysis and purification of small molecules.	Boiron Boiron is an independent family pharmaceutical group founded in 1932 by two pharmacists, Jean and Henri Boiron.	Asembia Asembia is a company that specializes in pharmacy contracting and patient support services.	China Medical System China Medical System (CMS) is a company that manufactures pharmaceutical products.	Navitus Health Solutions Navitus Health Solutions is a company that provides pharmacy benefit management solutions to the private and public sectors.
Founding Date	Founding Date 2011	Founding Date 1932	Founding Date 2004	Founding Date 1995	Founding Date 2003
Type	Type Private	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare healthtech pharma	Tags Healthcare healthtech pharma	Tags Healthcare healthtech pharma	Tags Healthcare healthtech pharma	Tags Healthcare healthtech pharma
Locations	Locations Nottingham, GB HQ	Locations Messimy, FR HQ Sofia, BG Saint Bruno De Montarville, CA Budapest, HU Mumbai, IN see more	Locations Florham Park, US HQ Bensalem, US Livingston, US Scottsdale, US	Locations George Town, KY HQ	Locations Madison, US HQ Appleton, US Austin, US Scottsdale, US
Employees	Employees 25	Employees 2,469	Employees 4361% increase	Employees 4,70019% decrease	Employees 1,6324% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €487.6m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) ¥8.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €61.6m (FY, 2024)	Cost of goods N/A	Cost of goods ¥2.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €426.9m (FY, 2024)	Gross profit N/A	Gross profit ¥6.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income €11.3m (FY, 2024)	Net income N/A	Net income ¥1.4b (FY, 2025)	Net income N/A
Operating ⚠
Trademark Applications (US)	Trademark Applications (US) N/A	Trademark Applications (US) N/A	Trademark Applications (US) 1 (Jun, 2024)	Trademark Applications (US) N/A	Trademark Applications (US) 3 (Jun, 2024)
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 4 (Jun, 2024)	Trademarks (US) N/A	Trademarks (US) 9 (Jun, 2024)